Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LINES trial of linsitinib in advanced Ewing sarcoma
ISRCTN94236001Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Apr 2014
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of linsitinib in Ewing sarcoma, sponsored by University of Oxford. Primary endpoint: FDG uptake (SUV) responses. Started Apr 2014; status: completed.
02
Drugs
linsitinib
03
Conditions
Ewing sarcoma
Beyond the preview
Go deeper on ISRCTN94236001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN94236001.